[Challenges and perspectives of antiplatelet therapy in the secondary prevention of vascular events].
Fernández-Concepción
Otman
O
González-García
Sergio
S
D001241:Aspirin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D000077144:Clopidogrel; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D055502:Secondary Prevention; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D016896:Treatment Outcome; D014652:Vascular Diseases / Q000188:drug therapy / Q000517:prevention & control
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin